Biochem/physiol Actions
Potent and selective dual inhibitor of EGFR (IC50 = 0.016 mM) and ErbB-2 receptor tyrosine kinase.
Features and Benefits
This compound is a featured product for Kinase Phosphatase Biology research. Click here to discover more featured Kinase Phosphatase Biology products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold for research purposes under agreement from GlaxoSmithKline
Molecular Weight: 395.46. Empirical Formula: C23H21N7. Quality Level: 100. Assay: ≥. 98% (HPLC). form: solid. color: yellow. solubility: DMSO: ≥. 20 . mg/mL. originator: GlaxoSmithKline. SMILES string: CN(C)c1cc2c(Nc3ccc4n(Cc5ccccc5)ncc4c3)ncnc2cn1. InChI: 1S/C23H21N7/c1-29(2)22-11-19-20(13-24-22)25-15-26-23(19)28-18-8-9-21-17(10-18)12-27-30(21)14-16-6-4-3-5-7-16/h3-13,15H,14H2,1-2H3,(H,25,26,28). InChI key: DYYZXRCFCVDSKD-UHFFFAOYSA-N. Gene Information: human ... EGFR(1956), ERBB2(2064). Storage Class Code: 11 - Combustible Solids. WGK: WGK 3. Flash Point(F): Not applicable. Flash Point(C): Not applicable. Personal Protective Equipment: Eyeshields, Gloves, type N95 (US).- UPC:
- 12352130
- Condition:
- New
- HazmatClass:
- No
- MPN:
- G0668-250MG
- CAS:
- 202272-68-2
akash.verma@cenmed.com
(732) 447-1115





